AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank50
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-29.83M
Near historical average
Percentile
P50
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-27.74M
Historical baseline
PeriodValueYoY Change
TTM$-29.83M+39.4%
2024$-49.26M+7.6%
2023$-53.29M-59.2%
2022$-33.46M-63.4%
2021$-20.48M-281.9%
2020$-5.36M-115.8%
2019$-2.49M-